176 related articles for article (PubMed ID: 26472977)
1. Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis.
Yang T; Yang Y; Liu S
J Breast Cancer; 2015 Sep; 18(3):264-70. PubMed ID: 26472977
[TBL] [Abstract][Full Text] [Related]
2. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
[TBL] [Abstract][Full Text] [Related]
3. Association of metformin use with cancer incidence and mortality: a meta-analysis.
Zhang P; Li H; Tan X; Chen L; Wang S
Cancer Epidemiol; 2013 Jun; 37(3):207-18. PubMed ID: 23352629
[TBL] [Abstract][Full Text] [Related]
4. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
5. Association of metformin use and cancer incidence: a systematic review and meta-analysis.
O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA
J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943
[TBL] [Abstract][Full Text] [Related]
6. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
[No Abstract] [Full Text] [Related]
7. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
8. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
9. Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.
Poly TN; Islam MM; Li YJ; Lin MC; Hsu MH; Wang YC
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441802
[TBL] [Abstract][Full Text] [Related]
10. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
11. Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
Wu GF; Zhang XL; Luo ZG; Yan JJ; Pan SH; Ying XR; Pan JG; Zhang GF
Int J Clin Exp Med; 2015; 8(8):13089-98. PubMed ID: 26550231
[TBL] [Abstract][Full Text] [Related]
12. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
13. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis.
Zhang ZJ; Li S
Diabetes Obes Metab; 2014 Aug; 16(8):707-10. PubMed ID: 24460896
[TBL] [Abstract][Full Text] [Related]
15. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
16. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
17. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis.
Fon Sing M; Yang WS; Gao S; Gao J; Xiang YB
Eur J Cancer Prev; 2011 May; 20(3):157-65. PubMed ID: 21403523
[TBL] [Abstract][Full Text] [Related]
19. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
Zhang H; Gao C; Fang L; Zhao HC; Yao SK
Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
